Yüklüyor......
Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy
Adeno-associated virus (AAV) was first characterized as small “defective” contaminant particles in a simian adenovirus preparation in 1965. Since then, a recombinant platform of AAV (rAAV) has become one of the leading candidates for gene therapy applications resulting in two FDA-approved treatments...
Kaydedildi:
| Yayımlandı: | Viruses |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8309980/ https://ncbi.nlm.nih.gov/pubmed/34201599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13071205 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|